Mortality and cancer incidence in ammonium perfluorooctanoate production workers

Occupational and Environmental Medicine

Volumn 71, Issue 7, 2014, Pages 500-506

  Raleigh, Katherine K ^a   Alexander, Bruce H ^a   Olsen, Geary W ^b   Ramachandran, Gurumurthy ^a   Morey, Sandy Z ^c   Church, Timothy R ^a   Logan, Perry W ^b   Scott, Laura L F ^a   Allen, Elizabeth M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b 3M COMPANY   (United States)

^c More Consulting Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; AMMONIUM PERFLUOROOCTANOIC ACID; PERFLUOROOCTANOIC ACID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; EMPLOYEE; FEMALE; HUMAN; INDUSTRIAL HYGIENE; ISCHEMIC HEART DISEASE; KIDNEY CANCER; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; OCCUPATIONAL SAFETY; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; STANDARDIZED MORTALITY RATIO; UNITED STATES;

ADULT; AGED; AMMONIUM COMPOUNDS; CAPRYLATES; CHEMICAL INDUSTRY; COHORT STUDIES; FEMALE; FLUOROCARBONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MINNESOTA; NEOPLASMS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; OCCUPATIONS; URINARY BLADDER NEOPLASMS; WISCONSIN;

EID: 84902329852     PISSN: 13510711     EISSN: 14707926     Source Type: Journal    
DOI: 10.1136/oemed-2014-102109     Document Type: Article

References (35)

1. Biegel LB, Hurtt ME, Frame SR, et al. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol Sci 2001;60:40-55.
2. Butenhoff JL, Kennedy GL Jr, Chang S-C, et al. Chronic dietary toxicity and carcinogenicity study with ammonium perfluorooctanoate in Sprague-Dawley rats. Toxicology 2012;298:1-13.
3. Frame SR, McConnell EE. Review of proliferative lesions of the excocrine pancreas in two chronic feeding studies in rats with ammonium perfluorooctanoate. Du Pont Laboratory Project Identification # 13788. 2003;AR226-1920. USEARN.
4. Elcombe CR, Elcombe BM, Foster JR, et al. Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats following dietary exposure to ammonium perfluorooctanoate occurs through increased activation of the xenosensor nuclear receptors PPARalpha and CAR/PXR. Arch Toxicol 2010;84:787-98.
5. Butenhoff J, Costa G, Elcombe C, et al. Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol Sci 2002;69:244-57.
6. Olsen GW, Zobel LR. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int Arch Occup Environ Health 2007;81:231-46. (Pubitemid 47617455)
7. Woskie SR, Gore R, Steenland K. Retrospective exposure assessment of perfluorooctanoic acid serum concentrations at a fluoropolymer manufacturing plant. Ann Occup Hyg 2012;56:1025-37.
8. Olsen GW, Mair DC, Church TR, et al. Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006. Environ Sci Technol 2008;42:4989-95. (Pubitemid 351956443)
9. Kato K, Wong LY, Jia LT, et al. Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008. Environ Sci Technol 2011;45:8037-45.
10. D 'Eon JC, Mabury SA. Is indirect exposure a significant contributor to the burden of perfluorinated acids observed in humans? Environ Sci Technol 2011;45:7974-84.
11. Frisbee SJ, Brooks AP Jr, Maher A, et al. The C8 health project: design, methods, and participants. Environ Health Perspect 2009;117:1873-82.
12. Steenland K, Woskie S. Cohort mortality study of workers exposed to perfluorooctanoic acid. Am J Epidemiol 2012;176:909-17.
13. National Toxicology Program. NTP toxicology and carcinogenesis studies of terafluoroethylene (CasNo. 116-14-3) in F344/N rats and B6C3F1 mice (inhalation studies). NIH Publication No. 97-3366. Research Triangle Park, NC: National Institute of Environmental Health Sciences, 1997.
14. Consonni D, Straif K, Symons JM, et al . Cancer risk among tetrafluoroethylene synthesis and polymerization workers. Am J Epidemiol 2013;178:350-8.
15. Gilliland FD, Mandel JS. Mortality among employees of a perfluorooctanoic acid production plant. J Occup Med 1993;35:950-4. (Pubitemid 23285042)
16. Lundin JI, Alexander BH, Olsen GW, et al. Ammonium perfluorooctanoate production and occupational mortality. Epidemiology 2009;20:921-8.
17. Schubauer-Berigan MK, Hein MJ, Raudabaugh WM, et al. Update of the NIOSH life table analysis system: a person-years analysis program for the windows computing environment. Am J Ind Med 2011;54:915-24.
18. Breslow NE, Day NE. Statistical methods in cancer research . Lyon: International Agency for Research on Cancer, 1987.
19. Barry V, Winquist A, Steenland K. Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant. Environ Health Perspect 2013;121:1313-18.
20. Eriksen KT, Sorensen M, McLaughlin JK, et al. Perfluorooctanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general Danish population. J Natl Cancer Inst 2009;101:605-9.
21. Vieira VM, Hoffman K, Shin HM, et al. Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis. Environ Health Perspect 2013;121:318-23.
22. Hardell E, Karrman A, van Bavel B, et al . Case-control study on perfluorinated alkyl acids (PFAAs) and the risk of prostate cancer. Environ Int 2014;63:35-9.
23. Sleeuwenhoek A, Cherrie JW. Exposure assessment of tetrafluoroethylene and ammonium perfluorooctanoate 1951-2002. J Environ Monit 2012;14:775-81.
24. Hardisty JF. Pathology peer review and pathology working group review of mammary glands from a chronic feeding study in rats of PFOA. U.S. EPA Docket AR-226. Research Triangle Park: Experimental Pathology Laboratories, Inc., 2005.
25. Bonefeld-Jorgensen EC, Long M, Bossi R, et al. Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: a case control study. Environ Health 2011;10:88.
26. Vanden Heuvel JP. Comment on "associations between PFOA, PFOS and changes in the expression of genes involved in cholesterol metabolism in humans " by Fletcher et al., Environment International 57-58 (2013) 2-10. Environ Int 2013;61:150-3.
27. Steenland K, Fletcher T, Savitz DA. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect 2010;118:1100-8.
28. Fletcher T, Galloway TS, Melzer D, et al. Associations between PFOA, PFOS and changes in the expression of genes involved in cholesterol metabolism in humans. Environ Int 2013;57-58:2-10.
29. C8 Science Panel. Probable Link Evaluation of Stroke. 2012. http://www.c8sciencepanel.org/pdfs/Probable-Link-C8-Stroke-30Jul2012.pdf
30. Simpson C, Winquist A, Lally C, et al. Relation between perfluorooctanoic acid exposure and strokes in a large cohort living near a chemical plant. Environ Res 2013;127:22-8.
31. C8 Science Panel. Probable Link Evaluation of Heart Disease. 2012. http://www.c8sciencepanel.org/pdfs/Probable-Link-C8-Heart-Disease-20Oct2012.pdf
32. Olsen GW, Burris JM, Burlew MM, et al. Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers. Drug Chem Toxicol 2000;23:603-20.
33. Olsen GW, Butenhoff JL, Mandel JH. Assessment of lipid, hepatic, and thyroid function in relation to an occupational biologic limit value for perfluorooctanoate. USEPA Public Docket AR-226-1351. Saint Paul: 3M Company, 2003.
34. Olsen GW, Church TR, Miller JP, et al. Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ Health Perspect 2003;111:1892-901. (Pubitemid 37541200)
35. Calafat AM, Kuklenyik Z, Reidy JA, et al. Serum concentrations of 11 polyfluoroalkyl compounds in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES). Environ Sci Technol 2007;41:2237-42. (Pubitemid 46595180)